E
Tactical Resources Corp. RARE.V
TSX
Recommendation
Sell
Prev Close
$0.325
Volume
--
Avg Vol (90D)
14,565
Market Cap
$8.05M
Dividend & Yield
--
52-Week Range
$0.085 - $0.67
P/E (TTM)
--
EPS (TTM)
-$0.1659
My Lists My Alerts
Rating
Reward
E
Very Weak
Risk
D-
Weak
Rating Factors
Growth Index
Very Weak
Efficiency Index
Very Weak
Solvency Index
Very Weak
Total Return Index
Weak
Volatility Index
Weak
Dividend Index
--
Headlines
How The Parts Add Up: VBK Headed For $340
3/17/2025 - ETF Channel
Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) Shares Sold by Great Lakes Advisors LLC
3/14/2025 - MarketBeat
Ultragenyx Pharmaceutical (RARE, $38.33) RSI Indicator left the oversold zone on March 11, 2025
3/12/2025 - Tickeron - Stocks
Insider Selling: Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) CFO Sells 1,785 Shares of Stock
3/11/2025 - MarketBeat
Have Insiders Sold Ultragenyx Pharmaceutical Shares Recently?
3/11/2025 - Simply Wall St
Insider Selling: Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) CFO Sells 1,785 Shares of Stock
3/11/2025 - MarketBeat
Ultragenyx Pharmaceutical (RARE, $38.62) RSI Indicator left the oversold zone on March 07, 2025
3/8/2025 - Tickeron - Stocks
Ultragenyx Pharmaceutical (RARE) Gets a Buy from J.P. Morgan
3/8/2025 - TipRanks Financial Blog
Insider Selling: Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) CEO Sells $3,091,571.40 in Stock
3/7/2025 - Ticker Report
Candriam S.C.A. Sells 38,835 Shares of Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE)
3/7/2025 - MarketBeat
Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) CAO Theodore Alan Huizenga Sells 967 Shares
3/6/2025 - MarketBeat
Insider Selling: Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) EVP Sells 6,028 Shares of Stock
3/6/2025 - MarketBeat
Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) Insider Sells $607,881.90 in Stock
3/6/2025 - MarketBeat
Insider Selling: Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) CEO Sells 25,000 Shares of Stock
3/6/2025 - MarketBeat
Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) CEO Sells $3,091,571.40 in Stock
3/6/2025 - MarketBeat
Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) CEO Emil D. Kakkis Sells 25,000 Shares
3/5/2025 - Ticker Report
Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) Insider John Richard Pinion Sells 14,439 Shares
3/5/2025 - MarketBeat
Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) Receives Consensus Rating of "Moderate Buy" from Brokerages
3/5/2025 - Ticker Report
Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) CAO Theodore Alan Huizenga Sells 967 Shares
3/5/2025 - Ticker Report
Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) Insider Sells $607,881.90 in Stock
3/5/2025 - Ticker Report
Insider Selling: Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) EVP Sells 2,990 Shares of Stock
3/4/2025 - MarketBeat
Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) EVP Sells $128,211.20 in Stock
3/3/2025 - MarketBeat
Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) Receives Consensus Rating of "Moderate Buy" from Analysts
2/28/2025 - MarketBeat
Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) Shares Purchased by Y Intercept Hong Kong Ltd
2/27/2025 - Ticker Report
Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) Shares Bought by Y Intercept Hong Kong Ltd
2/27/2025 - MarketBeat
Income Statement
Total Revenue (TTM)
--
EBITDA (TTM)
-$3.04M
EBIT (TTM)
-$3.04M
Net Income (TTM)
-$5.92M
Balance Sheet
Total Assets (Q)
$247.80K
Total Debt (Q)
$129.70K
Total Liabilities (Q)
$3.57M
Book Value Per Share (Q)
-$0.093
Cash Flow
Cash from Operations (TTM)
-$777.70K
Cash from Investing (TTM)
--
Cash from Financing (TTM)
$135.80K
Net Change in Cash (TTM)
-$641.90K
Filings
Filing Date
Tuesday, December 31, 2024
Period Date
Monday, September 30, 2024
Next Filing
Week of Mar 17 and 21 (est)
Price History
Loading...
Beta
-1.19
7-Day Total Return
-5.00%
30-Day Total Return
72.73%
60-Day Total Return
35.71%
90-Day Total Return
-2.56%
Year to Date Total Return
52.00%
1-Year Total Return
300.00%
2-Year Total Return
26.67%
3-Year Total Return
-63.46%
5-Year Total Return
--
52-week Low
Mar 28, 2024 - $0.085
52-week High
Aug 23, 2024 - $0.67
Valuation
Market Cap
$8.05M - Nano Cap
Enterprise Value
$8.13M
Price/Sales (TTM)
--
Price/Book (Q)
-3.49
Dividends and Shares
Shares Outstanding
35.67M
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
www.tacticalresources.com
Phone Number
778-588-5483
Address
1500 Royal Centre
1055 West Georgia Street - PO Box 11117
Vancouver, BC V6E 4N7
Country
Canada
Year Founded
2018
Business Description
Sector
Materials
Industry
Materials
Tactical Resources Corp. acquires, explores for, and develops mineral resource properties in Canada. The company primarily explores for rare earth element deposits. Its flagship property is the... more
Weiss Ratings